Log In
BCIQ
Print this Print this
 

Lyra Influenza A Subtype H7N9 Assay

  Manage Alerts
Collapse Summary General Information
Company Quidel Corp.
DescriptionReal-time reverse transcriptase PCR (rRT-PCR) for the in vitro qualitative detection and differentiation of influenza A (H7N9) virus viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect influenza A (H7N9) virus in patients with signs and symptoms of respiratory infection who have positive specimens for influenza A viral RNA that were determined to be “un-subtypable”
Regulatory Designation U.S. - Emergency Use Authorization (EUA) (Detect influenza A (H7N9) virus in patients with signs and symptoms of respiratory infection who have positive specimens for influenza A viral RNA that were determined to be “un-subtypable”)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today